News

• 27th May 2022

  Dante Labs highlights advancements to its drug discovery development program, demonstrating the value of genomic data to drug discovery

  NEW YORK, May 26, 2022 (GLOBE NEWSWIRE) -- Dante Genomics, a global leader in genomics and precision medicine, highlights significant progress made in its drug discovery development program with six d…

  Published by Laura D’Angelo

• 4th May 2022

  Dante Labs announces ventures into biosimulation and drug discovery, demonstrating the predictive value of the Dante Platform

  NEW YORK, April. 11, 2022 (GLOBE NEWSWIRE) -- Dante Labs, a global leader in genomic information and precision medicine, announces new genomic driven biosimulation and significant progress made to its…

• 4th May 2022

  Dante Labs selected to provide genetic testing for Abu Dhabi Stem Cells Center, jointly developing mRNA cancer vaccines

  NEW YORK, April 27, 2022 (GLOBE NEWSWIRE)-- Dante Labs, a global leader in genomics and precision medicine, is pleased to announce the company has been selected as the genetic testing provider for Abu…

• 4th May 2022

  Dante Labs establishes the first of its Regional Medical Genomics Boards in Europe made of national and multinational world leaders in genomics

  NEW YORK, March. 24, 2022 (GLOBE NEWSWIRE) -- Dante Labs, a global leader in genomics and precision medicine, announces the establishment of the first of its Medical Genomics Boards, strengthening the…

• 4th May 2022

  Dante Labs unveils Dante Genomics, the Company’s B2B global online marketplace delivering genomic solutions for medical professionals, researchers and pharma

  NEW YORK, March. 14, 2022 (GLOBE NEWSWIRE) -- Dante Labs, a global leader in genomics and precision medicine, today announced the launch of Dante Genomics, an online marketplace portal specifically de…